Stock 300039 SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Shanghai Kaibao Pharmaceutical CO.,Ltd

Equities

300039

CNE100000JZ3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
5.97 CNY -2.45% Intraday chart for Shanghai Kaibao Pharmaceutical CO.,Ltd -3.40% -10.23%
Apr. 25 Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Shanghai Kaibao Pharmaceutical CO.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent drugs. The Company's main product is Tanreqing injection, which is used for treatment of upper respiratory tract infections, such as cold and pneumonia. The Company's products include injections, tablets, capsules, granules, vinum and pills, among others. The Company distributes its products in domestic markets.

Number of employees: 1,380

Sales per Business

CNY in Million2022Weight2023Weight Delta
Injection
88.5 %
935 83.5 % 1,410 88.5 % +50.87%
Capsules
10.0 %
159 14.2 % 160 10.0 % +0.58%
Tablets
1.2 %
19 1.7 % 19 1.2 % +0.03%
Other Medicines
0.2 %
5 0.4 % 2 0.2 % -44.90%
Other
0.1 %
1 0.1 % 2 0.1 % +95.91%
Rental
0.1 %
1 0.1 % 1 0.1 % -23.19%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,119 100.0 % 1,594 100.0 % +42.47%

Managers

Managers TitleAgeSince
Ying Bin Zhou CEO
 Chief Executive Officer 46 17-11-09
Dong Sheng Xue CHM
 Chairman 54 -
Li Wang Ren DFI
 Director of Finance/CFO 54 18-10-24
Jing Wei Mu CHM
 Chairman 45 -
Ning Bo Zhao CTO
 Chief Tech/Sci/R&D Officer 45 04-12-31
Fa Kai Lu BRD
 Director/Board Member 37 -
Ke Ji Zhao BRD
 Director/Board Member 41 -
Cong Ying Ma IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Jing Wei Mu CHM
 Chairman 45 -
Li Wang Ren DFI
 Director of Finance/CFO 54 18-10-24
Zu Guang Ye BRD
 Director/Board Member 77 20-12-09
Dong Sheng Xue CHM
 Chairman 54 -
Ning Bo Zhao CTO
 Chief Tech/Sci/R&D Officer 45 04-12-31
Ying Bin Zhou CEO
 Chief Executive Officer 46 17-11-09
Ke Ji Zhao BRD
 Director/Board Member 41 -
Zhen Ni Li BRD
 Director/Board Member 49 20-12-09
Fa Kai Lu BRD
 Director/Board Member 37 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,046,000,000 611,816,842 ( 58.49 %) 0 58.49 %

Shareholders

NameEquities%Valuation
Yan Qi Zhang
15.14 %
160,790,370 15.14 % 137 M ¥
Xinxiang Kaiyi Industrial Co. Ltd.
7.382 %
78,425,019 7.382 % 67 M ¥
Jing Wei Mu
3.954 %
42,007,318 3.954 % 36 M ¥
Jing Nan Mu
0.7729 %
8,211,182 0.7729 % 7 M ¥
Xuan Jiang Chen
0.3389 %
3,600,000 0.3389 % 3 M ¥
Huai Jin Yuan
0.3116 %
3,310,482 0.3116 % 3 M ¥
Cheng Jun Wang
0.2924 %
3,106,000 0.2924 % 3 M ¥
China Universal Asset Management Co., Ltd.
0.2543 %
2,701,800 0.2543 % 2 M ¥
De Hong Feng
0.2438 %
2,590,000 0.2438 % 2 M ¥
Fullgoal Fund Management Co., Ltd.
0.1194 %
1,268,380 0.1194 % 1 M ¥
NameEquities%Valuation
Jing Wei Mu
97.36 %
126,021,952 97.36 % 107 M ¥
Li Wang Ren
1.113 %
1,440,894 1.113 % 1 M ¥

Holdings

NameEquities%Valuation
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.
16.39%
 19,002,728 16.39% 98,195,457 $

Company contact information

Shanghai Kaibao Pharmaceutical Co., Ltd.

88 Chengpu Road Comprehensive Industrial Dev Zone

201401, Shanghai

+

http://www.xykb.com
address Shanghai Kaibao Pharmaceutical CO.,Ltd(300039)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD Stock Shanghai Kaibao Pharmaceutical CO.,Ltd
-10.23% 884M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.69% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.28% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.49% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.24% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.12% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 244B
NOVARTIS AG Stock Novartis AG
+9.31% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-5.07% 205B
PFIZER, INC. Stock Pfizer, Inc.
-0.35% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300039 Stock
  4. Company Shanghai Kaibao Pharmaceutical CO.,Ltd